Goel David E. insider trades
Goel David E. has filed 5 Form 4s with the SEC that we hold, for SLRN (Director, 10% owner), Alumis INC. (NASDAQ) (Director, 10% owner), Aura Biosciences, Inc. (AURA) (10% owner) and Zentalis Pharmaceuticals, Inc. (ZNTL) (10% owner). Across all of them we count 1 purchase worth $25.0M and 1 sale worth $10.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($10.0M). The largest single trade was a purchase of 1,785,000 shares of Aura Biosciences, Inc. worth $25.0M, dated 2021-11-02. The first filing on our record is dated 2021-11-04 and the latest 2025-12-15.
SLRN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Alumis INC. (NASDAQ)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Aura Biosciences, Inc. (AURA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-02 | P, purchase reported on Form 4 | 1,785,000 | $25.0M | 2021-11-04 |
Zentalis Pharmaceuticals, Inc. (ZNTL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-12-15 | S, sale reported on Form 4 | 7,500,000 | $10.0M | 2025-12-15 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1548144) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms